Company Filing History:
Years Active: 2020
Title: Luis Montuenga Badía: Innovator in Lung Cancer Diagnosis
Introduction
Luis Montuenga Badía is a notable inventor based in Pamplona, Spain. He has made significant contributions to the field of medical diagnostics, particularly in the area of lung cancer. His innovative approach has the potential to improve the accuracy of lung cancer diagnosis and prognosis.
Latest Patents
Luis Montuenga Badía holds a patent related to lung cancer molecular markers. The invention provides a method for diagnosing and/or prognosing lung cancer by determining the level of a C4 activation fragment in a test sample. This method involves comparing the level of the C4 activation fragment in the test sample with that in a control sample. If the level in the test sample is higher than in the control, it indicates that the subject may suffer from lung cancer or have a poor prognosis. Additionally, the invention offers methods for assessing the risk of developing lung cancer and for evaluating the efficacy of medical regimens based on the C4 activation fragment.
Career Highlights
Throughout his career, Luis has worked with various organizations, including Proyecto de Biomedicina Cima, S.L. and Fundación para la Investigación Médica Aplicada. His work has focused on advancing medical research and developing innovative diagnostic methods.
Collaborations
Luis has collaborated with notable colleagues such as Daniel Ajona Martínez-Polo and Leticia Corrales Pecino. These collaborations have contributed to the advancement of research in the field of lung cancer diagnostics.
Conclusion
Luis Montuenga Badía is a pioneering inventor whose work in lung cancer molecular markers has the potential to transform diagnostic practices. His contributions to medical research highlight the importance of innovation in improving patient outcomes.